Introduction
Fungal infections, mainly in the form of vaginal candidosis, are common in patients attending genitourinary medicine clinics. However, infections affecting the AIDS patient extend this range of fungal disease considerably. The mycoses in AIDS patients include some of the commoner and more important complications of this disease such as oropharyngeal candidosis and pryptococcosis. Rarer examples include extensive dermatophytosis, histoplasmosis and penicillinosis (table) . The clinical diagnosis of most of these diseases usually needs to be confirmed by appropriate laboratory tests.1 2This is a particular problem in the AIDS patient where classical symptoms such as headache in meningitis may be minimal and clinical signs altered. Dermatophytosis, for instance, although not apparently commoner in the AIDS group may present with strikingly different clinical features compared with the otherwise healthy patient.3 Some of the rarer fungal infections which may also present in this group, such as histoplasmosis, sporotrichosis and penicillinosis, are not endemic in Europe and their recognition may be delayed because of unfamiliarity.
Candidosis
Infections due to yeasts belonging to the genus Candida are common occurrences in genitourinary medicine as in other branches of medicine. The infections range from superficial disease such as oral or vaginal infection to deep or systemic infections. Candida albicans or related species are commensals in the mouth, gastrointestinal tract and the vagina. The carriage rates vary considerably in different studies with 16-45% of the normal population being carriers. Infection is accompanied by a change in the status of the organism from saprophyte to parasite. In some, but not all, instances this' is accompanied by a change in Sampling for culture depends on the use of standard cotton tipped swabs.' These are best moistened in the transport medium prior to sampling. As with most microbial specimens delay in sending the material to the laboratory will result in results which are difficult to interpret as overgrowth with more rapidly growing bacteria may occur. In the oropharynx mouthwash samples may provide higher yields. The usual medium for isolation is Sabouraud's glucose peptone medium (1% mycological peptone, 4% glucose and 1.5% agar). This normally contains antibacterial antibiotics such as chloramphenicol (0005%) or penicillin (20 mg/l)/streptomycin (40 mg/l) to suppress bacterial growth. Where mixed infections are suspected dual plates will be needed. There are some commercially available kit systems specifically designed for isolation of yeasts from the vagina. Generally these are more expensive but include dip slides. In addition a latex test for detecting Candida antigen in the vagina has been developed although its success rate does not seem to exceed that using direct microscopy in experienced hands.5 Candida species are not generally fastidious and will grow on other non-specific media such as blood agar. Candida species as other yeasts are usually ready for identification within 48 hours. Specific culture methods are not usually necessary for the isolation of Candida from superficial sites but if the organisms are being sought in blood cultures there is some evidence that lysis centrifugation is a preferred method. 6 The identification of Candida species is then subsequently based on a simple test the germ tube test whereby the yeasts are incubated for 2 4 hours at 37°C in non-immune human serum. Candida albicans forms germ tubes, small outgrowths from the yeast cells under these conditions. This is a simple distinguishing test to separate C. albicans from the other species. There are occasional false positives particularly where C. tropicalis is present and if the test is incubated for longer than 2 hours. There are more detailed investigations available to the laboratory,7 the simplest of which the API system is based on the utilisation of sugars (for example API Laboratory Products Ltd); by presenting a battery of sugars in a strip culture it is possible to speciate most yeasts. More complex approaches such as culture morphology on different agars and assimilation reactions or restriction fragment analysis are used only in specialised laboratories;8 however, they have proved useful in tracking outbreaks of infection.9 10 Other approaches to recognition of Candida species such as the detection of amplified DNA fragments using the polymerase chain reaction have only recently been applied to the recognition of yeasts."
Superficial infections are usually caused by C. albicans although other species, such as C. glabrata, may be involved in vaginal candidosis. Topical antifungals work well against most species. However identification of the species may be helpful if there is doubt about the role of the organism isolated in causing disease or in chronic treatment unresponsive infections because the sensitivity of different Candida species to different orally active azole antifungals may vary.``For instance C. tropicalis is often less sensitive to ketoconazole; C. glabrata and C. krusei are less sensitive to fluconazole.
There is no need to use serodiagnosis in superficial candidosis although there are a number of serodiagnostic systems in use for systemic infections, most of which have important limitations.'4 15 Interpretation of laboratory results. Generally the best method of ensuring that the organisms isolated are pathogenic is by relating the culture results to the presence or absence of clinical disease. Clues from laboratory investigation, which may indicate the presence of infection rather than colonization, include the presence of hyphae -amongst yeasts seen in m-icroscopy of smears and the isolation of large numbers of organisms.
Other superficial infections
The commonest of the other superficial fungal infections is dermatophytosis, although pityriasis versicolor may also develop in some patients. The incidence of either disease is not increased in AIDS patients although dermatophytosis may be difficult to recognise because lesions appear atypical.'6 The normal laboratory diagnosis is simple and involves the use of direct microscopy and culture.'7 Samples are generally scrapings taken with a scalpel from the edge rather than the centre of lesions. The technique for microscopy is the same as that used for candidosis (5-10% potassium hydroxide). Dermatophyte cultures generally grow best at room temperature although it may take at least 7-10 days before the isolates are sufficiently well grown to identify. Scrapings for pityriasis versicolor are taken in the same way. It is not necessary to culture the organisms which are fastidious lipophilic yeasts as their microscopic appearances are typical. There is usually a mixture of round yeast forms and short stubby hyphae. A stain using a 1:1 mixture of Parker's Quink ink and potassium hydroxide (10%) will highlight these fungal elements very clearly and provides a rapid method of screening scrapings.
Cryptococcosis
Cryptococcosis is a systemic yeast infection caused by an encapsulated yeast, Cryptococcus neoformans. This is present in the environment particularly in areas contaminated with pigeon excreta. The route of infection is via the lungs but the commonest clinical manifestation is meningitis or another feature indicating dissemination eg skin or bone lesions. While it is thought that many individuals are sensitised, but not infected, after exposure, in the severely immunocompromised patient particularly those with T lymphocyte defects there is a higher risk of the emergence of clinical infection. The commonest underlying disease in cryptococcosis is AIDS. In the UK it causes disease in about 3% ofAIDS patients, whereas in Zaire the incidence of infection is higherabout 12%. 18 Cryptococcosis in AIDS patients differs to some degree to that seen in other groups. For instance there is a higher frequency of cryptococcaemia and the symptoms may be comparatively mild.'9 The principles of diagnosis however are the same whatever the patient's background.
Cryptococcus neoformans, which is an encapsulated organism, can be demonstrated by direct microscopy.' The usual techniques used for demonstrating the organisms in smears or CSF are the India ink or Nigrosin stains. Both techniques rely on the fact that the capsule will displace an opaque medium such as India ink particles and the clear halo around a single cell will represent the diagnostic capsule of the infecting organism. The method of carrying out the test is simple. A drop of material such as cerebrospinal fluid is mixed with an equal volume of India ink on a glass slide, covered with a coverslip and examined. Some macrophages can produce a similar phenomenon so the slide should be carefully scanned for budding yeasts; this is less likely to happen if nigrosin is used as the stain. Some cryptococci are only weakly encapsulated and these may be difficult to separate from lymphocytes. This may be more commonly seen in isolates from AIDS patients.20 Once again the presence of buds is diagnostic. 
Laboratory techniques in the investigation offungal infections
Cryptococcus neoformans is normally easy to isolate on Sabouraud's agar from clinical material.2 It grows best at 30-31°C and may appear slowly (up to 10 days) on primary isolation producing white to yellow colonies which may appear mucoid. C. neoformans produces urease and this forms the basis of a simple diagnostic test. It also turns brown on Guizotia abyssinica seed agar because of melanin production. Sugar assimilation can also be used for identification using the API system. The cultural identification of C neoformans is therefore specific and comparatively simple. Culture not only confirms the diagnosis it also provides some insight into prognosis. The rapidity of clearance of the organism from the CSF, for instance, is a good reflection of recovery in AIDS patients. Other sites which may harbour C. neoformans include skin, prostate21 and bone and in AIDS patients about 20- Unusual infections will occur in any group of immunocompromised patients and the identification of rare pathogens usually requires the help of a reference laboratory. Where a delay is likely it may be necessary to initiate treatment with a broad spectrum antifungal agent if the patient's condition is deteriorating. This can be changed if necessary later, although most fungal pathogens seen in AIDS patients will respond to amphotericin B.
